Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.
Public ClinicalTrials.gov record NCT04740827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prophylaxis of Migraine in Participants With Episodic Migraine Who Have Previously Failed 2 to 4 Classes of Oral Prophylactic Treatments (ELEVATE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in participants with episodic migraine and who have previously failed 2 to 4 classes of oral prophylactic treatments.
Study identification
- NCT ID
- NCT04740827
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 315 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2021 (Actual)
- Primary completion
- Aug 4, 2022 (Actual)
- Completion
- Aug 4, 2022 (Actual)
- Last update posted
- Sep 21, 2023
2021 – 2022
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Axiom Research /ID# 226379 | Colton | California | 92324 | — |
| Pharmacology Research Institute (PRI) - Encino (Wake) /ID# 226434 | Encino | California | 91316 | — |
| Pharmacology Research Institute (PRI) - Los Alamitos (Wake) /ID# 226388 | Los Alamitos | California | 90720-3500 | — |
| Pharmacology Research Institute (PRI) - Los Alamitos (Wake) /ID# 226405 | Los Alamitos | California | 90720-3500 | — |
| Excell Research, Inc /ID# 228386 | Oceanside | California | 92056 | — |
| Alpine Clinical Research Center /ID# 226201 | Boulder | Colorado | 80301-1880 | — |
| Sensible Healthcare /ID# 226197 | Ocoee | Florida | 34761 | — |
| Meridien Research /ID# 226224 | St. Petersburg | Florida | 33709 | — |
| Meridien Research /ID# 226302 | St. Petersburg | Florida | 33709 | — |
| Velocity Clinical Research - Boise /ID# 226320 | Meridian | Idaho | 83642 | — |
| Allied Physicians - Fort Wayne Neurological Center /ID# 226350 | Fort Wayne | Indiana | 46804 | — |
| Deaconess Clinic - Gateway Health Center /ID# 226481 | Newburgh | Indiana | 47630 | — |
| Pharmasite Research, Inc. /ID# 226445 | Baltimore | Maryland | 21208 | — |
| StudyMetrix Research /ID# 226297 | City of Saint Peters | Missouri | 63303 | — |
| Clinvest Research LLC /ID# 226273 | Springfield | Missouri | 65807 | — |
| Methodist Physicians Clinic /ID# 226470 | Fremont | Nebraska | 68025 | — |
| Amici Clinical Research - Raritan /ID# 226282 | Raritan | New Jersey | 08869 | — |
| Albuquerque Clinical Trials, Inc /ID# 233445 | Albuquerque | New Mexico | 87102 | — |
| CTI Clinical Trial and Consulting /ID# 226281 | Cincinnati | Ohio | 45212 | — |
| FutureSearch Trials of Neurology /ID# 226423 | Austin | Texas | 78731 | — |
| Austin Clinical Trial Partners /ID# 228387 | Austin | Texas | 78737 | — |
| DiscoveResearch, Inc /ID# 226491 | Bryan | Texas | 77802 | — |
| FutureSearch Trials of Dallas, LP /ID# 226493 | Dallas | Texas | 75231 | — |
| LinQ Research, LLC /ID# 226227 | Pearland | Texas | 77584 | — |
| Highland Clinical Research /ID# 226288 | Salt Lake City | Utah | 84124 | — |
| Northwest Clinical Research Center /ID# 226228 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04740827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04740827 live on ClinicalTrials.gov.